TORRENT PHARMACEUTICALS LTD. - 500420 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Scrutinizer''s Report on the Postal Ballot27-11-2023
27-11-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Torrent and Zydus sign licensing agreement for co-marketing Saroglitazar Mg, a critical treatment for chronic liver diseases in India10-11-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Issue of Duplicate Share Certificates09-11-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Credit Rating
Intimation of Credit Rating01-11-2023
Torrent Pharma price targets up, point to 12% upside
The average price target of brokerages compiled by Bloomberg is 2,159, implying an upside of 12% from Monday's closing.31-10-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement for completion of dispatch of Postal Ballot Notice.27-10-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Copy of Postal Ballot Notice.26-10-2023
Hold Torrent Pharma; target of Rs 1940: ICICI Securities
ICICI Securities recommended hold rating on Torrent Pharma with a target price of Rs 1940 in its research report dated October 24, 2023.26-10-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of conference call with Analysts / Investors on Financial Results for the quarter and half year ended 30th September, 202326-10-2023
Buy Torrent Pharmaceuticals; target of Rs 2250: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 2250 in its research report dated October 23, 2023.25-10-2023